炎症性肠病中的贫血
Anaemia in inflammatory bowel disease.
作者信息
Dibb Martyn, Subramanian Sreedhar
机构信息
Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
出版信息
Frontline Gastroenterol. 2014 Jul;5(3):190-196. doi: 10.1136/flgastro-2013-100388. Epub 2014 Jan 3.
Abstract
Anaemia is a common manifestation in inflammatory bowel disease (IBD) and impairs quality of life. Anaemia in IBD is typically caused by iron deficiency or anaemia of chronic disease. Treatment of iron deficiency with oral iron may lead to gastrointestinal intolerance though this may be related to the dose of iron replacement. New intravenous formulations have emerged which allow safe, rapid and effective correction of iron deficiency in IBD. In this article, we provide a review on the topic and cover recent progress in the field for the practicing gastroenterologist.
摘要
贫血是炎症性肠病（IBD）的常见表现，会损害生活质量。IBD中的贫血通常由缺铁或慢性病贫血引起。口服铁剂治疗缺铁可能会导致胃肠道不耐受，不过这可能与铁剂替代剂量有关。新的静脉制剂已出现，可安全、快速且有效地纠正IBD中的缺铁。在本文中，我们针对该主题进行综述，并为执业胃肠病学家介绍该领域的最新进展。
相似文献
1
Anaemia in inflammatory bowel disease.炎症性肠病中的贫血
Frontline Gastroenterol. 2014 Jul;5(3):190-196. doi: 10.1136/flgastro-2013-100388. Epub 2014 Jan 3.
2
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.炎症性肠病中铁缺乏性贫血的合理管理。
Nutrients. 2018 Jan 13;10(1):82. doi: 10.3390/nu10010082.
3
Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease.炎症性肠病中铁缺乏性贫血的管理。
Acta Haematol. 2019;142(1):30-36. doi: 10.1159/000496728. Epub 2019 Apr 10.
4
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.治疗炎症性肠病缺铁性贫血的干预措施。
Cochrane Database Syst Rev. 2021 Jan 20;1(1):CD013529. doi: 10.1002/14651858.CD013529.pub2.
5
Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of Life.胃肠病学家主导的炎症性肠病缺铁性贫血管理有效、安全且可能提高生活质量。
Crohns Colitis 360. 2020 Jul;2(3):otaa051. doi: 10.1093/crocol/otaa051. Epub 2020 Jun 24.
6
Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice.在常规日常实践中，羧甲麦芽糖铁治疗炎症性肠病患者缺铁性贫血的安全性和疗效。
J Crohns Colitis. 2018 Jun 28;12(7):826-834. doi: 10.1093/ecco-jcc/jjy042.
7
[Pathophysiological-based diagnosis and therapy of iron-deficient anaemia in inflammatory bowel disease].[炎症性肠病缺铁性贫血基于病理生理学的诊断与治疗]
Z Gastroenterol. 2009 Feb;47(2):228-36. doi: 10.1055/s-2008-1027876. Epub 2009 Feb 5.
8
Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study.德国炎症性肠病相关贫血和缺铁的诊断与管理现状：德国AnaemIBD研究
J Crohns Colitis. 2014 Oct;8(10):1308-14. doi: 10.1016/j.crohns.2014.03.010. Epub 2014 Apr 8.
9
Iron deficiency anemia in patients with inflammatory bowel disease.炎症性肠病患者的缺铁性贫血
Clin Exp Gastroenterol. 2013 Jun 4;6:61-70. doi: 10.2147/CEG.S43493. Print 2013.
10
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响：直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.
引用本文的文献
1
Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.口服蔗糖铁在治疗溃疡性结肠炎患者贫血方面与静脉注射羧基麦芽糖铁效果相当。
Nutrients. 2021 Feb 12;13(2):608. doi: 10.3390/nu13020608.
2
Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease.炎症性肠病患儿的微量营养素缺乏和贫血。
Nutrients. 2021 Jan 15;13(1):236. doi: 10.3390/nu13010236.
3
Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.缺铁治疗选择及静脉铁在常规临床实践中应用的问答
Ann Med. 2021 Dec;53(1):274-285. doi: 10.1080/07853890.2020.1867323.
本文引用的文献
1
Response: efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease.反应：促红细胞生成素联合肠内营养治疗克罗恩病贫血的疗效
Nutr Clin Pract. 2013 Aug;28(4):523. doi: 10.1177/0884533613487220. Epub 2013 Jun 4.
2
Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.缺铁会导致 IBD 患者发生继发性血小板增多和血小板活化：一项随机对照的血栓形成 VIT 试验。
Inflamm Bowel Dis. 2013 Jul;19(8):1609-16. doi: 10.1097/MIB.0b013e318281f4db.
3
Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders.维生素 B12 吸收：哺乳动物生理学及获得性和遗传性疾病。
Biochimie. 2013 May;95(5):1002-7. doi: 10.1016/j.biochi.2012.11.004. Epub 2012 Nov 20.
4
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.三价羧麦芽糖铁可预防炎症性肠病患者贫血复发。
Clin Gastroenterol Hepatol. 2013 Mar;11(3):269-77. doi: 10.1016/j.cgh.2012.10.013. Epub 2012 Oct 16.
5
Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden.炎症性肠病中贫血的低患病率：瑞典一项基于人群的研究。
Scand J Gastroenterol. 2012 Sep;47(8-9):937-42. doi: 10.3109/00365521.2012.672590. Epub 2012 May 10.
6
Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.铁剂治疗对炎症性肠病相关贫血患者血小板计数的影响。
PLoS One. 2012;7(4):e34520. doi: 10.1371/journal.pone.0034520. Epub 2012 Apr 10.
7
Micronutrient deficiencies in inflammatory bowel disease: from A to zinc.炎症性肠病中的微量营养素缺乏：从 A 到锌。
Inflamm Bowel Dis. 2012 Oct;18(10):1961-81. doi: 10.1002/ibd.22906. Epub 2012 Apr 5.
8
Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease.异麦芽糖酐铁1000在炎症性肠病患者中的药代动力学
Drug Des Devel Ther. 2012;6:43-51. doi: 10.2147/DDDT.S30015. Epub 2012 Mar 5.
9
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis.炎症性肠病缺铁性贫血患者的铁剂补充治疗：系统评价和荟萃分析。
J Crohns Colitis. 2012 Apr;6(3):267-75. doi: 10.1016/j.crohns.2011.09.010. Epub 2011 Oct 26.
10
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice.新的静脉用铁剂在医院应用后成本最小化的对比分析更新。
Ther Clin Risk Manag. 2011;7:501-9. doi: 10.2147/TCRM.S25882. Epub 2011 Dec 12.
Zotero 插件